Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYBR CyberCare the new look of healthcare -- Ignore unavailable to you. Want to Upgrade?

To: Murray_Mac who wrote (1992)	5/26/2000 7:56:00 AM
From: Murray_Mac	Read Replies (1) \| Respond to of 3392

CYBeR-CARE'S EHC 200 Model Deemed Exempt From FDA Approval BOYNTON BEACH, Fla., May 26, 2000 (BW HealthWire) -- CYBeR-CARE (Nasdaq:CYBR) received notification Thursday from the Food & Drug Administration that its Electronic HouseCall(TM) 200 (EHC 200) does not require FDA approval prior to sale or marketing and is considered to be a "general purpose device." CYBeR-CARE is currently awaiting approval on its Internet protocol/Intranet based system, the EHC 400. Based in Boynton Beach, FL, CYBeR-CARE is a technology-assisted disease management company with four business lines. The Company is developing the Electronic HouseCall(TM) System, a patented Internet-based technology system that provides remote monitoring of individuals for health care purposes, which is currently seeking 510(k) clearance from the Food and Drug Administration. In addition, CYBeR-CARE operates physical, occupational and speech therapy centers, an e-pharmacy and one of the world's largest air ambulance transport services. Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission. CONTACT: CYBeR-CARE, Inc., Boynton Beach Linda Moore, 561/737-2227 Website: cyber-care.net URL: businesswire.com Today's News On The Net - Business Wire's full file on the Internet with Hyperlinks to your home page. Copyright (C) 2000 Business Wire. All rights reserved.